首页> 外文期刊>The journal of gene medicine >Improving cellular uptake and in vivo tumor suppression efficacy of liposomal oligonucleotides by urea as a chemical penetration enhancer
【24h】

Improving cellular uptake and in vivo tumor suppression efficacy of liposomal oligonucleotides by urea as a chemical penetration enhancer

机译:通过尿素作为化学渗透促进剂提高脂质体寡核苷酸的细胞摄取和体内肿瘤抑制功效

获取原文
获取原文并翻译 | 示例
       

摘要

Background Liposomes are among the most widely used carriers for the delivery of antisense oligonucleotides (AsODNs) to intracellular targets. Although different strategies have been employed, the question of how to improve liposomal uptake and enhance the release of AsODN into cytoplasm still remains to be answered with respect to the use of a safe, easy and economic method. In the present study, the possibility of enhancing such processes at cellular and animal levels using urea as a penetration enhancer was investigated. Methods To perform this investigation, a cationic liposome containing an AsODN against protein kinase (PKC)-a was prepared, and the effect of urea on its cellular internalization and the related sequence-specific inhibition of gene expression in human lung adenocarcinoma A549 cells were investigated by flow cytometry and the reverse transcriptase-polymerase chain reaction, respectively. In in vivo studies, a xenograft lung tumor was established in nude mice by A549 cells and the enhancement effect of urea toward the effects of liposomal AsODN on tumor growth was investigated. Results Cellular studies revealed that urea treatment increases liposomal uptake and the release of AsODN into the cytoplasm by approximately 40%. Sequence-specific inhibition of target gene PKC-a expression was also increased by approximately two-fold by urea at 200–300 nM AsODN. In animal studies, urea significantly decreased the tumor volume (approximately 40%) and increased its doubling time from approximately 13 days to 17 days. Conclusions Urea, and possibly other membrane fluidizers, could be regarded as penetration enhancers for liposomal AsODN delivery and may improve the therapeutic effect of these gene-therapy vectors at both cellular and animal levels.
机译:背景脂质体是用于将反义寡核苷酸(AsODN)递送至细胞内靶标的最广泛使用的载体之一。尽管已经采用了不同的策略,但是关于如何使用安全,简便和经济的方法,如何改善脂质体的摄取和增加AsODN释放到细胞质中的问题仍然有待回答。在本研究中,研究了使用尿素作为渗透促进剂在细胞和动物水平上增强此类过程的可能性。方法进行这项研究,制备了一种含有针对蛋白激酶(PKC)-a的AsODN的阳离子脂质体,并研究了尿素对其细胞内在化和相关序列特异性抑制人肺腺癌A549细胞基因表达的影响。通过流式细胞术和逆转录酶-聚合酶链反应分别进行。在体内研究中,通过A549细胞在裸鼠中建立了异种移植肺肿瘤,并研究了尿素对脂质体AsODN对肿瘤生长的增强作用。结果细胞研究表明,尿素处理可增加脂质体摄取量,并将AsODN释放至细胞质中约40%。在200–300 nM AsODN下,尿素还可以使靶基因PKC-a表达的序列特异性抑制作用提高约两倍。在动物研究中,尿素可显着减少肿瘤体积(约40%),并将其倍增时间从约13天增加到17天。结论尿素,可能还有其他膜流化剂,可被视为脂质体AsODN递送的渗透促进剂,并可能在细胞和动物水平上改善这些基因治疗载体的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号